Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06033066 · ClinicalTrials.gov registry record · NA
Financial Incentives and Recruitment to the APT Webstudy
A NA study, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 44,844
- Enrollment target
NCT06033066: Completed NA study, sponsored by University of Southern California.
NCT06033066 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 44,844 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (3096% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06033066, a NA study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 44,844 participants
- Enrollment target
Study Summary
This single-blind, three-arm, randomized, controlled trial will assess the impact of messages and financial incentives on the enrollment of demographically diverse individuals to the Alzheimer Prevention Trials (APT) Webstudy. The APT Webstudy is a novel, online registry that employs quarterly cognitive testing using validated platforms. The APT Webstudy implements fully remote assessments, coordinated by the Alzheimer's Therapeutic Research Institute (ATRI) under USC IRB #HS-17-00746. The purpose of the current study is to test whether we can increase enrollment of diverse individuals into the registry. To do this, we will work with Contra Costa Regional Medical Center (CCRMC), the county public hospital and its affiliated health centers in Contra Costa County, California, to test whether sending messages with and without financial incentives to patients who receive primary care with the health system can increase enrollment to the APT Webstudy. The investigators hypothesize that 1) a certain small financial incentive and an award opportunity based incentive (or a drawing with a prize) will increase enrollment rates of CCHS members into the APT Webstudy relative to the control group. The investigators further hypothesize that the award opportunity incentive will increase the enrollment rate of CCRMC patients into the APT Webstudy more than a certain financial incentive with the same expected value.
Primary Outcome
APT Webstudy enrollment rate based on completion of at least one of the two APT Webstudy cognitive assessments (Cognitive Function Instrument \[CFI\] and/or Cogstate Brief Battery).
Interventions
- BEHAVIORAL Financial Incentives
- BEHAVIORAL Message
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44,844 participants |
| Start Date | 2024-03-01 |
| Est. Completion | 2024-04-30 |
| Phase | NA |
What the finished NCT06033066 record still lists
NCT06033066 is an interventional study that assigns participants to a tested intervention. Its 44,844 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (3096% higher).
The record links to 0 conditions, and to 2 interventions - of which Financial Incentives is the first listed.
NCT06033066 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06033066 about?
NCT06033066 is a clinical study titled "Financial Incentives and Recruitment to the APT Webstudy". This single-blind, three-arm, randomized, controlled trial will assess the impact of messages and financial incentives on the enrollment of demographically diverse individuals to the Alzheimer Prevention Trials (APT) Webstudy. The APT Webstudy is a novel, online registry that employs quarterly cogni...
What is the current status of trial NCT06033066?
This trial is currently completed. It is a NA study. The enrollment target is 44,844 participants. The study started on 2024-03-01. Estimated completion is 2024-04-30.
What interventions are being tested in trial NCT06033066?
The interventions under investigation include: Financial Incentives (BEHAVIORAL), Message (BEHAVIORAL).
Who is sponsoring clinical trial NCT06033066?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06033066's enrollment target sits among peer trials
44,844 7th of 2000 higher than 1,994 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05607732 · 45,257 participants · NA
Primary Care Detection of Cognitive Impairment Leveraging Health & Consumer Technologies in Underserved Communities: The MyCog Trial
- NCT06824350 · 45,450 participants · NA
Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates
- NCT06597968 · 45,991 participants
Evaluating the Real World Performance of an AI Based Lung Nodule Detection Tool
- NCT03977402 · 47,500 participants
Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI